N4P.L Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 10:24):

N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom...

Stats
Šios dienos apimtis	270 062
Vidutinė apimtis	759 144
Rinkos kapitalizacija	2.06M
EPS	£0 ( 2024-04-03 )
Last Dividend	£18.00 ( 1997-05-19 )
Next Dividend	£0 ( N/A )
P/E	-0.770
ATR14	£0.0360 (4.69%)

N4 Pharma PLC Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

N4 Pharma PLC Finansinės ataskaitos

Annual	2023
Pajamos:	£1 953.00
Bruto pelnas:	£1 953.00 (100.00 %)
EPS:	£-0.00520

FY	2023
Pajamos:	£1 953.00
Bruto pelnas:	£1 953.00 (100.00 %)
EPS:	£-0.00520

FY	2022
Pajamos:	£0
Bruto pelnas:	£0 (0.00 %)
EPS:	£-0.00550

FY	2021
Pajamos:	£0.00
Bruto pelnas:	£0.00 (0.00 %)
EPS:	£-0.00850

Financial Reports:

No articles found.

N4 Pharma PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)	£0 (N/A)

N4 Pharma PLC Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future

Information

First Dividend	£16.00	1995-05-22
Last Dividend	£18.00	1997-05-19
Next Dividend	£0	N/A
Payout Date	1997-07-01
Next Payout Date	N/A
# dividends	5	--
Total Paid Out	£85.20	--
Avg. Dividend % Per Year	0.00%	--
Score	1.05	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-10-21)

£0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

1.05

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield
1995	£0	0.00%
1996	£0	0.00%
1997	£0	0.00%
1998	£0	0.00%
1999	£0	0.00%
2000	£0	0.00%
2001	£0	0.00%
2002	£0	0.00%
2003	£0	0.00%
2004	£0	0.00%
2005	£0	0.00%
2006	£0	0.00%
2007	£0	0.00%
2008	£0	0.00%
2009	£0	0.00%
2010	£0	0.00%
2011	£0	0.00%
2012	£0	0.00%
2013	£0	0.00%
2014	£0	0.00%
2015	£0	0.00%
2016	£0	0.00%
2017	£0	0.00%
2018	£0	0.00%
2019	£0	0.00%
2020	£0	0.00%
2021	£0	0.00%
2022	£0	0.00%
2023	£0	0.00%
2024	£0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SHOE.L	Dividend Knight	2023-07-13	Annually	10	2.57%
III.L	Dividend King	2023-06-22	Semi-Annually	31	1.93%
BOWL.L	Dividend Knight	2023-06-08	Annually	8	1.03%
OOA.L	Dividend Knight	2023-07-27	Semi-Annually	17	2.87%
ETP.L	Dividend Knight	2023-08-17	Annually	3	0.19%
STEM.L	Dividend Knight	2023-11-09	Annually	19	1.82%
JTC.L	Dividend Knight	2023-09-21	Semi-Annually	7	0.79%
CBOX.L	Dividend Knight	2023-07-27	Semi-Annually	7	2.27%
PSON.L	Dividend King	2023-08-10	Semi-Annually	32	1.90%
GEC.L	Dividend Knight	2023-09-25	Quarterly	22	0.24%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-649.94	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.995	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.987	1.500	-10.00	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	14.86	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	14.73	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	12.57	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-0.00478	2.00	-0.00159	-0.00318	[0 - 30]
freeCashFlowPerShareTTM	-0.00478	2.00	-0.00239	-0.00478	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	1.000	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	-729.44	1.000	-10.00	-10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.00153	0.800	-3.32	-2.66	[0.5 - 2]
Total Score				-1.289

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-1.545	1.000	-0.257	0	[1 - 100]
returnOnEquityTTM	-0.987	2.50	-7.76	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.00478	2.00	-0.00159	-0.00478	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.00478	2.00	-0.00159	-0.00318	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.883	1.500	-9.22	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-619.10	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-3.03

N4 Pharma PLC

N4 Pharma Plc, a specialist pharmaceutical company, develops novel silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.